Stivarga 40 mg
Stivarga 40 mg is a medicine authorised by Swissmedic under authorisation number 62808. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 27 February 2013 and the authorisation is valid without a time limit. ATC code L01EX05 places the medicine in the group Antineoplastic agents.
| Authorisation number | 62808 |
|---|---|
| Name | Stivarga 40 mg |
| Full name | Stivarga 40 mg, Filmtabletten |
| Authorisation holder | Bayer (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EX05 |
| First authorisation | 27 February 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Stivarga 40 mg, Filmtabletten | A | 27 February 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 3 x 28 | Tablette(n) | L01EX05 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Stivarga 40 mg authorised in Switzerland?
Yes. Stivarga 40 mg is authorised by Swissmedic under authorisation number 62808, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Stivarga 40 mg have?
Stivarga 40 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Stivarga 40 mg?
The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.